主页 文献库文献详情
PMID: 42734457 已发表 · ppublish 英语

Experimental evidence for the beneficial effects of low-concentration ozone.

Medical gas research ·第 17 卷 ·第 1 期 ·2027-01-01

Carton F, Pellicciari C, Tabaracci G, Malatesta M

摘要

Ozone (O3), a molecule consisting of three oxygen atoms, is an unstable compound whose clinical application as a complementary therapy continues to expand. Although numerous clinical studies support its therapeutic potential, the molecular basis of its effects has remained poorly understood. This review summarizes the current knowledge on the cellular and molecular mechanisms activated by low-concentration O3. Central to its action is the induction of mild oxidative stress by low concentrations of O3, which triggers an antioxidant response mediated through nuclear factor erythroid 2-related factor 2, enhancing cell survival. Additionally, low-concentration O3 exhibits antiinflammatory properties by modulating cytokine expression, inhibiting metalloproteinases, and activating macrophages. The regenerative potential of low-concentration O3 may be attributed to the stimulation of fibroblasts, chondrocytes, and osteoblasts. Moreover, the antitumor effects of low-concentration O3 in cancer cell lines and animal models appear to be linked to the inhibition of cell proliferation and migration, as well as proapoptotic activity. More research is needed to determine the best treatment methods, long-term effectiveness, and standardized clinical procedures for ozone therapy in specific diseases. This review provides a detailed reference for understanding how O3 therapy works.

关键词
anti-inflammatory antioxidant antitumor apoptosis autophagy cell differentiation cell proliferation dose-dependent effect eustress oxidative stress regeneration
文献信息
期刊
Medical gas research
期刊简称
Med Gas Res
ISSN
2045-9912
发表日期
2027-01-01
语言
英语
国家/地区
Australia
NLM ID
101564536
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com